Agenus Competitors and Similar CompaniesClear all
Lyell's competitors and similar companies include Halozyme Therapeutics and LogicBio Therapeutics.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  LogicBio Therapeutics LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment. | ||
Founding Date | Founding Date 2018 | Founding Date 1998 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations San Diego, US HQ | Locations Lexington, US HQ Louisville, US |
Employees | Employees 188 | Employees 373157% increase | Employees 4178% increase |
Valuation ($) | Valuation ($) 243.3 m | Valuation ($) 6.4 b | Valuation ($) 176.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $5.4m (FY, 2021) |
Net income | Net income ($274.4m) (FY, 2025) | Net income $316.9m (FY, 2025) | Net income ($40m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 171.9m | Total funding raised $ 49m |
For sources of this data, please see the company profile
View Company Profiles
Halozyme Therapeutics
HQ
San Diego, US
Employees
373
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View companyLogicBio Therapeutics
HQ
Lexington, US
Employees
41
LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
View company